Parkman Healthcare Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26M | Sell |
33,296
-5,895
| -15% | -$4.6M | 2.98% | 7 |
|
|
2025
Q1 | $32.4M | Buy |
39,191
+11,028
| +39% | +$9.11M | 3.84% | 3 |
|
|
2024
Q4 | $21.7M | Sell |
28,163
-12,221
| -30% | -$9.43M | 2.9% | 7 |
|
|
2024
Q3 | $35.8M | Buy |
40,384
+8,730
| +28% | +$7.73M | 4.57% | 3 |
|
|
2024
Q2 | $28.7M | Sell |
31,654
-463
| -1% | -$419K | 3.84% | 4 |
|
|
2024
Q1 | $25M | Buy |
+32,117
| New | +$25M | 3.07% | 6 |
|
|
2023
Q2 | – | Sell |
-27,671
| Closed | -$9.5M | – | 101 |
|
|
2023
Q1 | $9.5M | Sell |
27,671
-6,767
| -20% | -$2.32M | 2.07% | 15 |
|
|
2022
Q4 | $12.6M | Sell |
34,438
-847
| -2% | -$310K | 3.35% | 5 |
|
|
2022
Q3 | $11.4M | Buy |
+35,285
| New | +$11.4M | 3.24% | 6 |
|